Phase I Study VG2025 as a Single Agent and in Combination Therapy With Nivolumab in Subjects With Advanced Malignant Solid Tumors
for Solid Tumor
Drug: Nivolumab
Sites in Gilbert +1 more location
Sponsor: Virogin Biotech Canada Ltd
Sex: All·Age: 18+
Code: NCT05266612·Phase 1·Recruiting·Listed Mar 2022